Lumayas.com is a site dedicated to Amelia Cahillane's musings on trading, technology, & the financial markets.

February 1, 2019

I'm starting to think I enjoy collecting these FINRA series licenses for fun or something.

I did it with the Series 3 Commodities Futures exam a few years back.

I studied for months, got the license, then immediately took a job at a financial tech startup building rules...

November 12, 2018

Last week, Editas Medicine, CRISPR Therapeutics, and Intellia Therapeutics released their third quarter financial results.

All three of the biotech companies are currently developing treatments using CRISPR-Cas9 gene editing technology. They are also all still pre...

November 6, 2018

One area of the biotech industry I find particularly interesting is genetic engineering.

For the past few months, I've been closely following the race between three similar publicly traded companies, all of which are competing to get the first genome editing t...

October 31, 2018

In honor of Halloween, one of my absolute favorite holidays, I felt it was fitting to write about zombie cells a.k.a. “senescent” cells, and one of the companies trying to defeat them. Senescent cells no longer divide and accumulate with age, causing tissue damage with...

October 26, 2018

I tried to write a serious post on my recent experience of actively attempting to make myself believe in buy and hold investing, but realized I am a ridiculous person, so it’s only semi-serious as it’s an actual play-by-play of my thought processes.  

Since this ended u...

October 12, 2018

On Wednesday, the FDA finally lifted their hold on CRISPR Therapeutics (NASDAQ:CRSP) and Vertex Pharmaceuticals' (NASDAQ:VRTX) CRISPR-Cas9 US clinical trial for their drug CTX001. The treatment aims to implement gene editing to treat sickle cell disease and if the tria...

March 19, 2018

Know the Psychology of Your Opponent

Understanding human psychology helps exponentially with the pursuit of success in any field, especially trading. In addition to understanding how your own emotions and behaviors impact position management, being able to identify how...

January 20, 2018

I’ve always been fascinated by electronic trading and my strong desire to progress the evolution of trade automation technology is one of the things that has kept me pushing forward in the fintech industry. I’ve seen many hurdles as the role of financial institutions i...

January 12, 2018


This week, the SEC halted industry efforts to deliver 12 bitcoin ETFs and two cryptocurrency mutual funds. This news came in the wake of last month’s release of two bitcoin futures contracts, the first trading on the Cboe (XBT) and the second on the CME (BTC).


January 10, 2018

After reading a very insightful piece by former derivatives trader and current philosophical essayist Nassim Nicholas Taleb, my eyes have been opened to how institutions should be created to better withstand volatility.

 Many know Taleb for his Black Swan theory, which...

Please reload

Recent Posts

Please reload


Please reload


Please reload